mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies.
Sztankovics D, Moldvai D, Petővári G, Dankó T, Szalai F, Miyaura R, Varga V, Nagy N, Papp G, Pápay J, Krencz I, Sebestyén A.
Sztankovics D, et al. Among authors: szalai f.
Pathol Oncol Res. 2024 Mar 7;30:1611643. doi: 10.3389/pore.2024.1611643. eCollection 2024.
Pathol Oncol Res. 2024.
PMID: 38515456
Free PMC article.
Review.